Estimates of the Prevalence and Number of Fibromyalgia Syndrome Patients and Their Alpha-1 Antitrypsin Phenotypic Distribution in Ten Countries

Ignacio Blanco Department of Internal Medicine, Hospital Valle del Nalón, 33920 Langre, Principado de Asturiaso, SpainCorrespondence[email protected]

Frederick de Serres National Institute of Environmental Health Sciences, Laboratory of Molecular Toxicology, Environmental Toxicology Program, P.O. Box 12233, Research Triangle Park, NC, 27709-2233

Sabina Janciauskiene Department of Clinical Sciences, Malmö University Hospital, 20502, Malmö, Sweden

Daniel Arbesú Department of Rehabilitation Medicine, Hospital Valle del Nalón, 33920 Langreo, Principado de Asturias, Spain

Enrique Fernández-Bustillo Biostatistics Unit, Hospital Universitario Central de Asturias, 33006 Oviedo, Principado de Asturias, Spain

Victoriano Cárcaba Department of Internal Medicine, Hospital Valle del Nalón, 33920 Langre, Principado de Asturiaso, Spain

Izabela Nita Department of Clinical Sciences, Malmö University Hospital, 20502, Malmö, Sweden

Aurora Astudillo Department of Pathology, Hospital Universitario Central de Asturias, 33006 Oviedo, Principado de Asturias, Spain

show all

Estimates of the Prevalence and Number of Fibromyalgia Syndrome Patients and Their Alpha-1 Antitrypsin Phenotypic Distribution in Ten Countries

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Estimates of the Prevalence and Number of Fibromyalgia Syndrome Patients and Their Alpha-1 Antitrypsin Phenotypic Distribution in Ten Countries

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date